日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular-clinical characteristics and treatment outcomes in 163 metastatic colorectal neuroendocrine carcinomas with a comparison to colorectal adenocarcinomas

163例转移性结直肠神经内分泌癌的分子临床特征和治疗结果,并与结直肠腺癌进行比较

Morken, Siren; Langer, Seppo W; Hjortland, Geir Olav; Sundlöv, Anna; Hofsli, Eva; Ladekarl, Morten; Tabaksblat, Elizaveta; Vestermark, Lene Weber; Svensson, Johanna; Knigge, Ulrich; Nunes, Luís; Glimelius, Bengt; Pfeiffer, Per; Aasebø, Kristine; Assmus, Jörg; Vassella, Erik; Lothe, Inger Marie Bowitz; Couvelard, Anne; Perren, Aurel; Knappskog, Stian; Sorbye, Halfdan

Characteristics, Prognosis and Reasons for Opting-Out of Treatment in Patients with Untreated Pancreatic Cancer

未接受治疗的胰腺癌患者的特征、预后及选择退出治疗的原因

Ladekarl, Morten; Stender, Mogens Tornby

Characteristics, treatment, and outcome of recurrent gastro-oesophageal adeno-carcinoma after perioperative chemotherapy and radical resection

围手术期化疗和根治性切除术后复发性胃食管腺癌的特征、治疗和预后

Larsen, Anders Christian; Shim, Susy; Bæksgaard, Lene; Pfeiffer, Per; Nordsmark, Marianne; Sørensen, Jan Reiter; Brøndum, Rasmus; Motavaf, Anne Krejbjerg; Ladekarl, Morten

Safety of [(68)Ga]Ga-FAPI-46 PET/CT including hemodynamic measurements and patient-reported outcomes in cancer patients

[(68)Ga]Ga-FAPI-46 PET/CT 在癌症患者中的安全性,包括血流动力学测量和患者报告结局

Bentestuen, Morten; Sylvest, Camilla; Jensen, Svend B; Soro, Lara R; Knudsen, Aage; Ladekarl, Morten; Thorlacius-Ussing, Ole; Fendler, Wolfgang P; Zacho, Helle D

The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST

利用ctDNA-RECIST评估早期ctDNA动力学对转移性胰腺癌预后的影响

Steiniche, Mette M; Lindgaard, Sidsel C; Chen, Inna M; Johansen, Julia S; Andersen, Rikke F; Hansen, Torben F; Jensen, Lars H; Rasmussen, Louise S; Johansen, Malene W; Ladekarl, Morten; Jakobsen, Anders K M; Spindler, Karen-Lise G

Longer survival with precision medicine in late-stage cancer patients

精准医疗延长晚期癌症患者的生存期

Mapendano, C K; Nøhr, A K; Sønderkær, M; Pagh, A; Carus, A; Lörincz, T; Haslund, C A; Poulsen, L Ø; Ernst, A; Bødker, J S; Dahl, S C; Sunde, L; Brügmann, A H; Vesteghem, C; Pedersen, I S; Ladekarl, M

Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study

一项前瞻性队列研究纳入了 639 例晚期高级别消化道神经内分泌肿瘤(NET G3 和 NEC),旨在探讨其特征和治疗结果。该研究为 NORDIC NEC 2 研究。

Sorbye, Halfdan; Hjortland, Geir Olav; Vestermark, Lene Weber; Ladekarl, Morten; Svensson, Johanna; Sundlöv, Anna; Janson, Eva Tiensuu; Garresori, Herish; Hofsli, Eva; Kersten, Christian; Elvebakken, Hege; Pfeiffer, Per; Morken, Siren; Assmus, Jorg; Lothe, Inger Marie Bowitz; Tabaksblat, Elizaveta; Knigge, Ulrich; Couvelard, Anne; Perren, Aurel; Langer, Seppo W

Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study

更正:一项前瞻性队列研究纳入639例晚期高级别消化道神经内分泌肿瘤(NET G3和NEC),探讨其特征和治疗结果。NORDIC NEC 2研究

Sorbye, Halfdan; Hjortland, Geir Olav; Vestermark, Lene Weber; Ladekarl, Morten; Svensson, Johanna; Sundlöv, Anna; Janson, Eva Tiensuu; Garresori, Herish; Hofsli, Eva; Kersten, Christian; Elvebakken, Hege; Pfeiffer, Per; Morken, Siren; Assmus, Jorg; Lothe, Inger Marie Bowitz; Tabaksblat, Elizaveta; Knigge, Ulrich; Couvelard, Anne; Perren, Aurel; Langer, Seppo W

Twenty-one-year report from the Danish Health Authority Expert Advisory Panel for review of treatment of 10 000 cancer patients

丹麦卫生局专家咨询小组对10000名癌症患者的治疗情况进行了为期21年的审查,并提交了一份报告。

Ladekarl, Morten; Mørk, Mette Louise; Albertsen, Emma Skotte; Nielsen, Dorte; Lassen, Ulrik; Mau-Sørensen, Morten; Nielsen, Claus Malta; Jakobsen, Anders; von der Maase, Hans

ABCG2 protein expression in tumors of patients with non-resectable pancreatic cancer treated with gemcitabine and nab-paclitaxel.

吉西他滨和白蛋白紫杉醇治疗不可切除胰腺癌患者肿瘤中 ABCG2 蛋白的表达

Shim Susy, Nielsen Mette Bak, Eld Mikkel, Stenvang Jan, Brøndum Rasmus Froberg, Weber Britta, Motavaf Anne Krejbjerg, Ladekarl Morten